ArticleBiology open2026
Histone and non-histone protein acetylation in a tail regeneration model (Ambystoma mexicanum).
Article in Biology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Histone deacetylase inhibitors (HDACi) potently inhibit appendage regeneration, but how HDACi alter protein acetylation is relatively unexplored. Using genomic, transcriptomic, and proteomic approaches, we report HDACi-mediated changes in gene expression and protein acetylation at the outset of Ambystoma mexicanum tail regeneration. HDACi (romidepsin) treatment globally reversed a genome-wide deacetylation response after tail amputation, broadly increasing H3K9ac and H3K27ac within intergenic regions, gene promoters, and gene bodies. Changes in promoter acetylation were only weakly associated with changes in gene expression when considering all acetylated genes. However, the magnitude of acetylation change was significantly greater for upregulated genes, including previously identified regeneration-inhibitory genes. We further detected hundreds of differentially acetylated non-histone proteins after tail amputation, including proteins that function in transcriptional regulation and hemostasis. We used a small molecule (A-485) to inhibit differentially acetylated transcription factors (Crebbp/Ep300) to show their requirement for tail regeneration. A-485 downregulated many of the same genes that were downregulated by romidepsin, but the upregulated gene set was relatively unique. Our results implicated histone and non-histone protein acetylation in the early transcriptional regulation of regeneration associated genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.